PDS Biotechnology (PDSB) Tax Provisions (2014 - 2025)
PDS Biotechnology's (PDSB) quarterly Tax Provisions came in at -$7.5 million in Q4 2025, down 540.25% on a QoQ basis from -$1.2 million in Q1 2025.
PDS Biotechnology (PDSB) Tax Provisions (2014 - 2025) Analysis & Trends
PDS Biotechnology (PDSB) has 7 years of Tax Provisions data on file, last reported at -$7.5 million in Q4 2025.
- Quarterly Tax Provisions changed N/A year-over-year to -$7.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$8.7 million (down 896.3% YoY) and the FY2025 annual result came in at -$7.5 million, down 761.71% from the prior year.
- Tax Provisions fell to -$7.5 million in Q4 2025, from -$1.2 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $1095.0 in Q4 2022 to a low of -$7.5 million in Q4 2025.
- A 5-year average of -$2.1 million and a median of -$1.2 million in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions jumped 73.45% — and 2023, when it plunged 99.82%.
- Tracing PDSB's Tax Provisions over 5 years: stood at -$4.5 million in 2021, then jumped by 100.02% to $1095.0 in 2022, then sank by 99.82% to $2.0 in 2023, then sank by 43458550.0% to -$869169.0 in 2024, then plunged by 761.71% to -$7.5 million in 2025.
- The last three Tax Provisions figures came in at -$7.5 million (Q4 2025), -$1.2 million (Q1 2025), and -$869169.0 (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | PDS Biotechnology | 12.02 Mn | 12.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.49 Mn |
| Mar 31, 2025 | -1.17 Mn |
| Jun 30, 2024 | -869,169.00 |
| Dec 31, 2023 | 2.00 |
| Jun 30, 2023 | -1.41 Mn |
| Dec 31, 2022 | 1,095.00 |
| Jun 30, 2022 | -1.20 Mn |
| Jun 30, 2021 | -4.52 Mn |
| Dec 31, 2015 | -1.11 Mn |
| Dec 31, 2014 | -590,675.00 |